Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSolmaz, V.
dc.contributor.authorAksoy, D.
dc.contributor.authorYurtogullari, S.
dc.contributor.authorSemiz, M.
dc.contributor.authorAydemir, E.
dc.contributor.authorErbas, O.
dc.date.accessioned2020-12-02T18:00:14Z
dc.date.available2020-12-02T18:00:14Z
dc.date.issued2016
dc.identifier.issn1302-0471
dc.identifier.urihttps://doi.org/10.5455/Gülhane.182271
dc.identifier.urihttp://hdl.handle.net/11446/3577
dc.description.abstractL-arginine (L-ARG)-nitric oxide (NO)-cGMP (cyclic guanosine monophosphate) cycle has been determined in various studies to be associated with epilepsy. Tadalafil is a potent inhibitor of phosphodiesterase 5 (PDE5) and increases the level of cGMP. Methylene blue (MB) is a lipophilic agent regulating intracellular electron flow as well as increasing the mitochondrial effectiveness. It also decreases cGMP levels by directly inhibiting guanylate cyclase.The aim of the present study was to evaluate the effects of MB and tadalafil on pentylenetetrazol-induced seizures. MB and tadalafil were administered 30 min prior to PTZ (70 mg/kg, i.p.) injection and the dose-response ratio was determined. Racine's Convulsion Scale and first myoclonic jerk (FMJ) onset time was used to evaluate seizures. Besides, drugs were administered 30 min prior to pentylenetetrazol (35 mg/kg, i.p.) injection and EEG was recorded from cortex and the spike wave discharges was determined in EEG. Plasma cGMP levels were measured in all groups. 5 and 10 mg/kg MB decreased Racine convulsion stage, increased FMJ onset time and decreased cGMP levels when compared with saline. 10 mg/kg tadalafil increased cGMP levels and Racine convulsion stage but decreased FMJ onset time compared with saline. Spike wave discharges were decreased in 5 and 10 mg/kg MB groups and increased in 10 mg/ kg tadalafil group when compared with saline group.The proconvulsant properties of all the agents may be taken into consideration, especially when prescribing PDE5 inhibitors. © Gülhane Tip Fakültesi 2016.en_US
dc.language.isoengen_US
dc.publisherGulhane Medical School, University of Health Sciencesen_US
dc.identifier.doi10.5455/Gülhane.182271en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEpilepsyen_US
dc.subjectMethyleneblueen_US
dc.subjectPentylenetetrazoleen_US
dc.subjectTadalafilen_US
dc.titleThe effects of methylene blue and tadalafil in pentylenetetrazole induced convulsion modelen_US
dc.typearticleen_US
dc.relation.journalGulhane Medical Journalen_US
dc.departmentDBÜen_US
dc.identifier.issue3en_US
dc.identifier.volume58en_US
dc.identifier.startpage286en_US
dc.identifier.endpage290en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempSolmaz, V., Department of Neurology, Turhal state hospital, Tokat, Turkey; Aksoy, D., Department of Neurology, Gaziosmanpasa University Medical Faculty, Tokat, Turkey; Yurtogullari, S., Department of Neurology, Kirikkale Postgraduate Degree State Hospital, Kirikkale, Turkey; Semiz, M., Department of Psychiatry, Gülhane Medical Faculty, Ankara, Turkey; Aydemir, E., Department of Psychiatry, Gülhane Medical Faculty, Ankara, Turkey; Erbas, O., Department of Physiology, Bilim Universty Medical Faculty, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster